Kiryu Yoshihiro
Department of Pharmacy, M&B Collaboration Medical corporation Hokuetsu Hospital.
Yakugaku Zasshi. 2022;142(4):319-326. doi: 10.1248/yakushi.21-00178-1.
Industrial reforms utilizing artificial intelligence (AI) have been progressing remarkably around the world in recent years. In medical informatics, the application of medical big data analytics using AI is also being promoted, and it is expected to provide screening methods for predicting potential adverse drug reactions (ADRs) and discovering new effects. Previously, we developed a unique ADRs analysis system that incorporates Accord.NET, an open-source machine learning (ML) framework written in the programming language C#, and uses the Japanese Adverse Drug Event Report (JADER) database. By using this system to analyze ADRs and screening the cause and severity of ADRs, information can be obtained to evaluate efficacy as well as ADRs. Although both statistical methods and ML are commonly used for prediction, a characteristic difference between them is that the former emphasizes causal relationships and the latter emphasizes prediction results. Therefore, it is important to distinguish between cases where decisions must be made with an emphasis on causality and those where decisions must be made by focusing on unknown risks, and statistical methods and ML should be selected and used as appropriate. Against this backdrop, this paper describes a use case and suggests that the proper use of AI tools to analyze medical big data will help clinical pharmacists practice optimal drug management for each patient.
近年来,利用人工智能(AI)的产业改革在全球范围内取得了显著进展。在医学信息学领域,使用AI进行医学大数据分析的应用也在不断推进,有望为预测潜在药物不良反应(ADR)和发现新效应提供筛查方法。此前,我们开发了一个独特的ADR分析系统,该系统集成了用C#编程语言编写的开源机器学习(ML)框架Accord.NET,并使用日本药品不良反应事件报告(JADER)数据库。通过使用该系统分析ADR并筛查ADR的原因和严重程度,可以获得评估疗效以及ADR的信息。虽然统计方法和ML都常用于预测,但它们之间的一个显著区别是,前者强调因果关系,而后者强调预测结果。因此,区分必须强调因果关系进行决策的情况和必须关注未知风险进行决策的情况非常重要,应根据情况适当选择和使用统计方法和ML。在此背景下,本文描述了一个用例,并表明正确使用AI工具分析医学大数据将有助于临床药师为每位患者实施最佳药物管理。